Unknown

Dataset Information

0

Integrative Analysis Reveals Across-Cancer Expression Patterns and Clinical Relevance of Ribonucleotide Reductase in Human Cancers.


ABSTRACT: Mining cancer-omics databases deepens our understanding of cancer biology and can lead to potential breakthroughs in cancer treatment. Here, we propose an integrative analytical approach to reveal across-cancer expression patterns and identify potential clinical impacts for genes of interest from five representative public databases. Using ribonucleotide reductase (RR), a key enzyme in DNA synthesis and cancer-therapeutic targeting, as an example, we characterized the mRNA expression profiles and inter-component associations of three RR subunit genes and assess their differing pathological and prognostic significance across over 30-types of cancers and their related subtypes. Findings were validated by immunohistochemistry with clinical tissue samples (n = 211) collected from multiple cancer centers in China and with clinical follow-up. Underlying mechanisms were further explored and discussed using co-expression gene network analyses. This framework represents a simple, efficient, accurate, and comprehensive approach for cancer-omics resource analysis and underlines the necessity to separate the tumors by their histological or pathological subtypes during the clinical evaluation of molecular biomarkers.

SUBMITTER: Ding Y 

PROVIDER: S-EPMC6788385 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Integrative Analysis Reveals Across-Cancer Expression Patterns and Clinical Relevance of Ribonucleotide Reductase in Human Cancers.

Ding Yongfeng Y   Zhong Tingting T   Wang Min M   Xiang Xueping X   Ren Guoping G   Jia Zhongjuan Z   Lin Qinghui Q   Liu Qian Q   Dong Jingwen J   Li Linrong L   Li Xiawei X   Jiang Haiping H   Zhu Lijun L   Li Haoran H   Shen Dejun D   Teng Lisong L   Li Chen C   Shao Jimin J  

Frontiers in oncology 20191004


Mining cancer-omics databases deepens our understanding of cancer biology and can lead to potential breakthroughs in cancer treatment. Here, we propose an integrative analytical approach to reveal across-cancer expression patterns and identify potential clinical impacts for genes of interest from five representative public databases. Using ribonucleotide reductase (RR), a key enzyme in DNA synthesis and cancer-therapeutic targeting, as an example, we characterized the mRNA expression profiles an  ...[more]

Similar Datasets

| S-EPMC5916795 | biostudies-literature
| S-EPMC3641363 | biostudies-literature
| S-EPMC4751996 | biostudies-literature
| S-EPMC8792945 | biostudies-literature
| S-EPMC5560700 | biostudies-other
| S-EPMC8243325 | biostudies-literature
| S-EPMC5528300 | biostudies-other
| S-EPMC3458845 | biostudies-literature
| S-EPMC3466523 | biostudies-literature
| S-EPMC4171582 | biostudies-literature